eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone for a Female patient aged 42

This is a personalized study for a 42 year old female patient. The study is created by eHealthMe based on reports of 20 people who take the same drugs and have drug interactionsfrom FDA.

On Nov, 27, 2014: 20 people who reported to have interactions when taking Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone are studied

Trend of Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone's drug interactions, side effects, and effectiveness reports (3087507)

Information of the patient in this study:

Age: 42

Gender: female

Conditions: Alpha Haemolytic Streptococcal Infection, Epstein-barr Virus Infection

Drugs taking:
- Ceftriaxone
- Gentamicin
- Vancomycin Hcl
- Prednisone

Drug interactions have: Splenomegaly, Respiratory Distress, Endocarditis, Alpha Haemolytic Streptococcal Infection, Acute Myocardial Infarction

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 42 (±5):

InteractionNumber of reports
Splenomegaly (enlargement of spleen)2 (40.00%)
Respiratory Distress (difficulty in breathing)2 (40.00%)
Endocarditis (inflammation in heart muscle)2 (40.00%)
Alpha Haemolytic Streptococcal Infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)2 (40.00%)
Acute Myocardial Infarction (acute heart attack)2 (40.00%)

Most common interactions experienced by females aged 42 (±5) in the use of Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone:

InteractionNumber of reports
Drug Rash With Eosinophilia And Systemic Symptoms (adverse drug reactions with rash)5
Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)5
Cytolytic Hepatitis (dissolution or destruction of a liver cell)5
Human Herpesvirus 6 Infection5
Myalgia (muscle pain)5
Human Herpes Virus 6 Serology Positive5
Renal Failure Acute (rapid kidney dysfunction)5
Arthralgia (joint pain)5
Endocarditis (inflammation in heart muscle)2
Respiratory Distress (difficulty in breathing)2

Most common interactions experienced by females aged 42 (±5) in long term use of Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Splenomegaly (enlargement of spleen)2 (10.00%)
Respiratory Distress (difficulty in breathing)2 (10.00%)
Endocarditis (inflammation in heart muscle)2 (10.00%)
Alpha Haemolytic Streptococcal Infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)2 (10.00%)
Acute Myocardial Infarction (acute heart attack)2 (10.00%)

Most common interactions experienced by people in the use of Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone:

InteractionNumber of reports
Drug Rash With Eosinophilia And Systemic Symptoms (adverse drug reactions with rash)20
Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)20
Thrombocytopenia (decrease of platelets in blood)16
Human Herpes Virus 6 Serology Positive16
Rash (redness)16
Arthralgia (joint pain)14
Hepatocellular Injury (liver injury)10
Acute Respiratory Distress Syndrome (sudden failure of the respiratory (breathing) system)10
Cardiac Failure10
Respiratory Failure (inadequate gas exchange by the respiratory system)10

Most common interactions experienced by people in long term use of Ceftriaxone, Gentamicin, Vancomycin Hcl, Prednisone:

InteractionNumber of reports
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)3
Respiratory Failure (inadequate gas exchange by the respiratory system)3
Acute Respiratory Distress Syndrome (sudden failure of the respiratory (breathing) system)3
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)3
Cardiac Failure3
Thrombocytopenia (decrease of platelets in blood)3
Hepatocellular Injury (liver injury)3
Abdominal Pain2
Diarrhoea2
Blood Disorder2

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.